S. Nightingale

发表

Electronic Orange Book

S. Nightingale, 1999 .

New Food Label to Enhance Healthful Diets

S. Nightingale, 1993 .

Drug regulation and policy formulation.

S. Nightingale, 1981, The Milbank Memorial Fund quarterly. Health and society.

The association between narcolepsy and REM behavior disorder (RBD).

S. Nightingale, A. Williams, I. Ebrahim, 2005, Sleep medicine.

Teleconference on Natural Rubber/Latex Allergy

S. Nightingale, 1998 .

From the Food and Drug Administration.

J. Samet, S. Nightingale, Neal L. Benowitz, 1998, JAMA.

Generic drugs and the prescribing physician.

S. Nightingale, J. Morrison, 1987, JAMA.

Written patient information on prescription drugs. The evolution of government and voluntary programs in the United States.

S. Nightingale, 1995, International journal of technology assessment in health care.

Quinine for nocturnal leg cramps?

S. Nightingale, 1995, ACP journal club.

From the Food and Drug Administration.

S. Nightingale, 1990, JAMA.

FDA Expanded Access Programs for Experimental Medicines.

S. Nightingale, 2015, Journal of the American Medical Association (JAMA).

Dietary supplement use: significant information in the medical history.

S. Nightingale, 1993, JAMA.

CLINICAL TRIALS IN THE UNITED STATES

S. Nightingale, 1989, The Lancet.

Proposals for Folic Acid Fortification and Labeling of Certain Foods to Reduce Risk of Neural Tube Defects

S. Nightingale, 1993 .

New Cancer Therapy Initiatives

S. Nightingale, 1996 .

From the Food and Drug Administration.

S. Nightingale, 1992, JAMA.

Appropriate Use of Low-Molecular-Weight Heparins (LMWHs)

S. Nightingale, 1993 .

From the Food and Drug Administration.

S. Nightingale, 1998, JAMA.

New Warnings Added to Cisapride Labeling

S. Nightingale, 1998 .

New Prescribing Information About Standardized Grass Pollen Extracts

S. Nightingale, 1998 .

New Mammography Screening Aid Approved

S. Nightingale, 1998 .

The Efficacy of Generic Primidone

S. Nightingale, P. Rheinstein, J. Morrison, 1989 .

Seafood safety.

S. Nightingale, 1990, American family physician.

The FDA's new procedures for the use of investigational drugs in treatment.

S. Nightingale, F. Young, J. A. Levitt, 1988, JAMA.

From the Food and Drug administration.

S. Nightingale, S L Nightingale, 1990, JAMA.

Research involving human subjects in developing countries.

S. Nightingale, G. Koski, G Koski, 2001, The New England journal of medicine.

Thalidomide Approved for Erythema Nodosum Leprosum

S. Nightingale, 1998 .

FDA's newly designated treatment INDs.

S. Nightingale, F. Young, 1988, JAMA.

Physical and Mental Pathology Due to Drug Addiction

S. Nightingale, 1973 .

5 – THE MANAGEMENT OF METHADONE INTOXICATION

S. Nightingale, 1976 .

Fluoxetine Labeling Revised to Identify Phenytoin Interaction and to Recommend Against Use in Nursing Mothers

S. Nightingale, 1994 .

Viagra Approval Information on the Internet

S. Nightingale, 1998 .

Hypersensitivity to Chlorhexidine-Impregnated Medical Devices

S. Nightingale, 1998 .

From the Food and Drug Administration.

S. Nightingale, 1993, JAMA.

Seafood Safety Hot Line

S. Nightingale, 1995 .

Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States.

S. Nightingale, J. Prasher, Stewart Simonson, 2007, Emerging infectious diseases.

FDA Seeks Input From Stakeholders

S. Nightingale, Stuart L. Nightingale, 1998 .

New Requirement for Patient Labeling for Selected Prescription Drug Products

S. Nightingale, 1999 .

New Rule Requires Labeling Information for Pediatric Use

S. Nightingale, 1999 .

Video Program on Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

S. Nightingale, 1998 .

New Drug to Treat HIV/AIDS Approved

S. Nightingale, 1998 .

Aerosolized pentamidine. Approved for HIV-infected individuals at high risk for Pneumocystis carinii pneumonia.

S. Nightingale, F. Young, C. Trapnell, 1989, Archives of internal medicine.

Monitoring of adverse drug events in hospitals.

D. Kennedy, S. Nightingale, J. Johnson, 1991, JAMA.

Evolving patterns of drug abuse.

S. Nightingale, R. Dupont, M. H. Greene, 1975, Annals of internal medicine.

Emergency Services and Drug Abuse

S. Nightingale, R. Dupont, R. Dormer, 1975 .

Off-label use of prescription drugs.

S. Nightingale, 2003, American family physician.

FDA Electronic Bulletin Board

S. Nightingale, 1995 .

The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarction.

F E Young, S. Nightingale, F. Young, 1988, JAMA.

Treatment IND for Advanced Pancreatic Cancer Authorized

S. Nightingale, 1995 .

Zalcitabine Approved for Use in Combination With Zidovudine for HIV Infection

S. Nightingale, 1992 .

Internet Purchase of Prescription Drugs: Buyer Beware

S. Nightingale, J. Shuren, J. Henney, 1999, Annals of Internal Medicine.

Warning About Use of Protective Restraint Devices

S. Nightingale, 1992 .

Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)

S. Nightingale, 1993 .

Promotional Practices of Pharmacy Benefits Management Companies

S. Nightingale, 1998 .

Important Information Regarding Alendronate Adverse Reactions

S. Nightingale, 1996 .

The Role of Data Audits in Detecting Scientific Misconduct

S. Nightingale, F. Kelsey, 1990 .

Irradiation of Meat Approved for Pathogen Control

S. Nightingale, 1998 .

Tobramycin Inhalation Product Approved for Use in Cystic Fibrosis Therapy

S. Nightingale, 1998 .

Scientific publication and global security.

S. Nightingale, 2011, JAMA.

From the Food and Drug Administration.

S. Nightingale, 1994, JAMA.

Patient information program of the FDA.

S. Nightingale, L. Morris, E. C. Tocus, 1983, Journal of psychoactive drugs.

Alendronate Approved for Bone Disorders

S. Nightingale, 1995 .

From the Food and Drug Administration.

S. Nightingale, 1990, JAMA.

Celecoxib for arthritis.

S. Nightingale, 1999, The Medical letter on drugs and therapeutics.

Dronabinol Approved for Use in Anorexia Associated With Weight Loss in Patients with AIDS

S. Nightingale, 1993 .

Marijuana and heroin by prescription? Recent developments at the state and federal levels.

S. Nightingale, S. Perry, 1979, JAMA.

How laetrile laws affect MDs.

S. Nightingale, F. D. Arnold, 1978, Legal aspects of medical practice.

Two New Therapies Available Under Treatment IND

S. Nightingale, 1992 .

Wide Access Protocols for Breast Implants Approved

S. Nightingale, 1992 .

Fat Substitute Olestra Approved

S. Nightingale, 1996 .

From the Food and Drug Administration.

S. Nightingale, 1990, JAMA.

medWatch Conference Cosponsored by the FDA and the AMA

S. Nightingale, 1993 .

Trovafloxacin Public Health Advisory

S. Nightingale, 1999 .

FDA Modernization Act of 1997

S. Nightingale, 1998 .

Access to investigational drugs for treatment purposes.

S. Nightingale, P. Rheinstein, C. Kimbrough, 1994, American Family Physician.

Immunoaugmentative therapy: assessing an untested therapy.

S. Nightingale, 1988, JAMA.

Detection of Group B Streptococcal Infection-Reply

S. Nightingale, 1997 .

From the Food and Drug Administration.

S. Nightingale, 1991, JAMA.

Laetrile: the regulatory challenge of an unproven remedy.

S. Nightingale, 1984, Public health reports.

From the Food and Drug Administration.

S. Nightingale, 1994, JAMA.

The patient information and education initiative.

S. Nightingale, P. Rheinstein, T. J. McGinnis, 1995, American family physician.